HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: 2361040338v1 236/1/166    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grazioli, L. Articles by Schneider, G. Search for Related Content PubMed PubMed Citation Articles by Grazioli, L. Articles by Schneider, G.

Accurate Differentiation of Focal Nodular Hyperplasia from Hepatic Adenoma at Gadobenate Dimeglumine–enhanced MR Imaging: Prospective Study¹

¹ From the Department of Radiology, University of Brescia, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25023 Brescia, Italy (L.G.); Department of Diagnostic Radiology, Ospedale Cà Foncello, Treviso, Verona, Italy (G.M.); Worldwide Medical Affairs, Bracco Imaging, Milan, Italy (M.A.K.); and Department of Diagnostic Radiology, University Hospital, Homburg/Saar, Germany (G.S.). Received February 20, 2004; revision requested April 29; revision received July 15; accepted September 2. Address correspondence to L.G. (e-mail: lgrazioli{at}yahoo.com).

PURPOSE: To prospectively determine the accuracy of differentiating benign focal nodular hyperplasia (FNH) from hepatic adenoma (HA) and liver adenomatosis (LA) by using gadobenate dimeglumine–enhanced magnetic resonance (MR) imaging.

MATERIALS AND METHODS: The ethics committee at each center approved the study, and all patients provided informed consent. Seventy-three patients with confirmed FNH and 35 patients with confirmed HA (n = 27) or LA (n = 8) underwent MR imaging before (T2-weighted half-Fourier rapid acquisition with relaxation enhancement or T2-weighted fast spin-echo and T1-weighted gradient-echo [GRE] sequences) and at 25–30 seconds (arterial phase), 70–90 seconds (portal venous phase), 3–5 minutes (equilibrium phase), and 1–3 hours (delayed phase) after (T1-weighted GRE sequences only, with or without fat suppression) bolus administration of 0.1 mmol per kilogram of body weight gadobenate dimeglumine. The enhancement of 235 lesions (128 FNH, 32 HA, and 75 LA lesions) relative to the normal liver parenchyma was assessed. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy for the differentiation of FNH from HA and LA were determined.

RESULTS: Hyper- and isointensity on T2-weighted and iso- and hypointensity on T1-weighted GRE images were noted for 177 (88.9%) of 199 lesions visible on unenhanced images. On dynamic phase images after contrast material administration, 231 (98.3%) of 235 lesions showed rapid strong enhancement during the arterial phase and appeared hyper- to isointense during portal venous and equilibrium phases. Accurate differentiation of FNH from HA and LA was not possible on the basis of precontrast or dynamic phase images alone. At 1–3 hours after contrast material enhancement, 124 (96.9%) of 128 FNHs appeared hyper- or isointense, while 107 (100%) HA and LA lesions appeared hypointense. The sensitivity, specificity, PPV, NPV, and overall accuracy for the differentiation of FNH from HA and LA were 96.9%, 100%, 100%, 96.4%, and 98.3%, respectively.

CONCLUSION: Accurate differentiation of FNH from HA and LA is achievable on delayed T1-weighted GRE images after administration of gadobenate dimeglumine.

© RSNA, 2005

This article has been cited by other articles:

				A. C. Silva, J. M. Evans, A. E. McCullough, M. A. Jatoi, H. E. Vargas, and A. K. Hara MR Imaging of Hypervascular Liver Masses: A Review of Current Techniques RadioGraphics, March 1, 2009; 29(2): 385 - 402. [Abstract] [Full Text] [PDF]

				S. W. Anderson, J. B. Kruskal, and R. A. Kane Benign Hepatic Tumors and Iatrogenic Pseudotumors RadioGraphics, January 1, 2009; 29(1): 211 - 229. [Abstract] [Full Text] [PDF]

				P. Della Vigna, L. Preda, L. Monfardini, M. S. P. Gorone, F. A. Maffini, and M. Bellomi Growing Perivascular Epithelioid Cell Tumor of the Liver Studied With Contrast-Enhanced Ultrasonography and Magnetic Resonance Imaging J. Ultrasound Med., December 1, 2008; 27(12): 1781 - 1785. [Full Text] [PDF]

				O. Giovanoli, M. Heim, L. Terracciano, G. Bongartz, and H. P. Ledermann MRI of Hepatic Adenomatosis: Initial Observations with Gadoxetic Acid Contrast Agent in Three Patients Am. J. Roentgenol., May 1, 2008; 190(5): W290 - W293. [Abstract] [Full Text] [PDF]

				T. K. Kim, H.-J. Jang, P. N. Burns, J. Murphy-Lavallee, and S. R. Wilson Focal Nodular Hyperplasia and Hepatic Adenoma: Differentiation with Low-Mechanical-Index Contrast-Enhanced Sonography Am. J. Roentgenol., January 1, 2008; 190(1): 58 - 66. [Abstract] [Full Text] [PDF]